Akums Drugs & Pharmaceuticals Stock Scales New 52-Week Peak at Rs 831: Key Reasons Behind the Surge

Published: 22 September 2026 at 9:18 AM IST

Akums Drugs & Pharmaceuticals Share Price opened the session at Rs 830.85, matched its fresh 52-week high at the same level, and later traded at Rs 822, up Rs 0.75 or 0.09% from the previous close of Rs 821.25. The company’s market capitalisation stood at Rs 12,338.9 crore, placing today’s move in a clearly visible market-cap context. The session is relevant because the supplied data confirms a fresh 52-week high, but it does not establish a company-specific catalyst.

For readers tracking Akums Drugs & Pharmaceuticals Share Price Today, the current quote, the day’s range and the turnover of Rs 0.13 crore show that the stock has already printed a yearly high while continuing to trade close to that mark. This Akums Drugs & Pharmaceuticals Stock News item therefore matters as a price-event update rather than a cause-led story. Univest is covering the verified move, the valuation backdrop and the company’s sector position so the Akums Drugs & Pharmaceuticals Share Price story can be read with the relevant context.

Akums Drugs & Pharmaceuticals Share Price Today: Price Action Analysis

Metric	Value
Current Price	Rs 822
Previous Close	Rs 821.25
Today's Move	+Rs 0.75 (+0.09%)
Open	Rs 830.85
High	Rs 830.85
Low	Rs 820.45
Turnover	Rs 0.13 crore
Market Capitalisation	Rs 12,338.9 crore

Akums Drugs & Pharmaceuticals Ltd. (AKUMS) traded at Rs 822 versus the previous close of Rs 821.25, a rise of 0.09%. The stock opened at Rs 830.85, reached a high of Rs 830.85 and touched a low of Rs 820.45.

Akums Drugs & Pharmaceuticals Share Price Today reflects a narrow positive change from the previous close, with Rs 822 versus Rs 821.25, a rise of Rs 0.75 or 0.09%. The session opened at Rs 830.85, which also stands as the day’s high and the fresh 52-week high, while the low was Rs 820.45. That means the stock spent the day trading in a tight band around its yearly high rather than far away from it.

The gap between the previous close and the fresh 52-week high is Rs 9.60, and the breakout over the prior high equals 1.17%. For Akums Drugs & Pharmaceuticals Share Price, the practical reading is simple: the stock marked a new 52-week peak and then held close to that level through the session. The move is best read as a verified price event in Akums Drugs & Pharmaceuticals Share Price Live data, with turnover of Rs 0.13 crore adding a factual traded-value reference. Univest notes the event without assigning an unsupported trigger, and the next question is how the fundamentals and sector comparisons frame that price level.

Akums Drugs & Pharmaceuticals Ltd. (AKUMS) Fundamental Analysis

Metric	Value
Market Capitalisation	Rs 12,338.9 crore
P/E Ratio	44.31x
P/B Ratio	3.78x
ROE	8.06%
ROCE	14.77%
EPS	Rs 18.53
Book Value Per Share	Rs 216.98
Dividend Yield	0.37%

Akums Drugs & Pharmaceuticals Ltd. (AKUMS) fundamental metrics show P/E 44.31x, P/B 3.78x, ROE 8.06%, ROCE 14.77%. These figures provide context only and are not a buy or sell signal.

Akums Drugs & Pharmaceuticals Ltd. has a market capitalisation of Rs 12338.9 crore, which gives readers a sense of company size before judging valuation. On valuation, P/E at 44.31x, P/B at 3.78x should be read against the sector and peer benchmarks rather than as a standalone signal. Profitability is represented by ROE of 8.06% and ROCE of 14.77%, helping investors compare shareholder returns and capital efficiency. Additional supplied metrics include EPS of Rs 18.53, book value per share of Rs 216.98, dividend yield of 0.37%, adding context to earnings, balance-sheet value and historical payout. Against the supplied same industry benchmark, these figures can be compared with benchmark median P/E of 32.39x, median ROE of 11.78%, median ROCE of 13.61%. These numbers explain the fundamental backdrop without converting the article into a buy or sell view.

Sector and Industry Context

Metric	Value
Sector	Healthcare
Industry	Pharmaceuticals & Drugs
Benchmark Scope	same industry
Company P/E Ratio	44.31x
Benchmark Median P/E	32.39x
Benchmark Average P/E	49.54x
Benchmark P/E Range	3.37x to 747.32x
Company P/B Ratio	3.78x
Benchmark Median P/B	2.98x
Company ROE	8.06%
Benchmark Median ROE	11.78%
Company ROCE	14.77%
Benchmark Median ROCE	13.61%
Company Market Capitalisation	Rs 12,338.9 crore
Benchmark Median Market Cap	Rs 729.99 crore

Akums Drugs & Pharmaceuticals Ltd. (AKUMS) is classified under sector: Healthcare and industry: Pharmaceuticals & Drugs.

Akums Drugs & Pharmaceuticals Ltd. (AKUMS) has a P/E ratio of 44.31x, which is above the benchmark median of 32.39x, a difference of +36.8%. P/E is a valuation multiple and is not, by itself, a buy or sell signal.

Akums Drugs & Pharmaceuticals Ltd. (AKUMS) has a ROE of 8.06%, which is below the benchmark median of 11.78%, a difference of -31.58%. Akums Drugs & Pharmaceuticals Ltd. (AKUMS) has a ROCE of 14.77%, which is above the benchmark median of 13.61%, a difference of +8.52%.

Track stocks reaching yearly peaks through the Univest 52-week-high screener. The peer table below provides the company-level comparison.

Peer Comparison

Company	Symbol	Market Cap (Cr)	P/E	P/B	ROE (%)	ROCE (%)
Sudeep Pharma Ltd.	SUDEEPPHRM	13,045	70.77	13.99	25.37	28.5
CORONA Remedies Ltd.	CORONA	13,447.57	68.04	16.78	27.36	31.74
Strides Pharma Science Ltd.	STAR	11,245.07	18.58	3.48	20.31	18.57
Sequent Scientific Ltd.	VIYASH	11,036.28	64.97	3.95	9.06	13.1
Blue Jet Healthcare Ltd.	BLUEJET	10,887.14	46.7	4.9	19.88	27.18

Akums Drugs & Pharmaceuticals Ltd. (AKUMS) has a P/E ratio of 44.31x compared with the displayed peer median of 64.97x. This is a relative valuation comparison, not a buy or sell signal. Its ROE of 8.06% compares with a peer median of 20.31% across the companies shown in the table. ROCE stood at 14.77% versus the displayed peer median of 27.18%, providing a capital-efficiency comparison. Akums Drugs & Pharmaceuticals Ltd. (AKUMS) has a market capitalisation of Rs 12,338.9 crore. Among the 5 peers shown, 2 have a larger market capitalisation.

Why Investors Are Watching Akums Drugs & Pharmaceuticals

• Akums Drugs & Pharmaceuticals Share Price touched a fresh 52-week high of Rs 830.85.
• The current price was Rs 822, which is Rs 0.75 above the previous close of Rs 821.25.
• Market capitalisation stood at Rs 12,338.9 crore.
• P/E ratio was 44.31 and P/B ratio was 3.78, with EPS at Rs 18.53 and book value at Rs 216.98.
• ROE was 8.06% and ROCE was 14.77% versus the industry benchmark figures in the same sector snapshot.

About Akums Drugs & Pharmaceuticals

Akums Drugs & Pharmaceuticals Ltd. operates in the Healthcare sector and the Pharmaceuticals & Drugs industry. This article uses the company’s verified market-capitalisation, valuation, return and financial statement data, along with the same-industry benchmark set, to frame the latest Akums Drugs & Pharmaceuticals Share Price update. For readers following Akums Drugs & Pharmaceuticals Company News or Akums Drugs & Pharmaceuticals Latest News, the key point is that the stock has reached a fresh one-year high while the supplied fundamentals and sector comparisons remain central to the story. Univest uses only the verified dataset to keep the Company Overview factual and current.

Track Akums Drugs & Pharmaceuticals Share Price on Univest

Use Akums Drugs & Pharmaceuticals Ltd. (AKUMS) live share-price page, Univest 52-week-high screener, Univest market blogs to review live stock data, yearly-high lists and related market analysis.

Readers can track Akums Drugs & Pharmaceuticals Share Price on Univest for live price updates, 52-week levels, market capitalisation, fundamentals, shareholding pattern and market insights. Univest also presents the same company in a structured format so users can follow Akums Drugs & Pharmaceuticals Share Price Today alongside sector and peer context.

Frequently Asked Questions

What is Akums Drugs & Pharmaceuticals Share Price today?

Ans. Akums Drugs & Pharmaceuticals Share Price today was Rs 822, up Rs 0.75 or 0.09% from the previous close of Rs 821.25. The stock also touched a fresh 52-week high of Rs 830.85.

What happened to Akums Drugs & Pharmaceuticals Share Price today?

Ans. The stock touched a fresh 52-week high at Rs 830.85, then traded at Rs 822. The day opened at Rs 830.85, and the session low was Rs 820.45, showing a tight intraday range.

Is Akums Drugs & Pharmaceuticals at a 52-week high?

Ans. Yes. Akums Drugs & Pharmaceuticals Share Price hit a fresh 52-week high of Rs 830.85 in today’s session. That level also matched the day’s high, making it the latest yearly peak in the supplied data.

What is the market capitalisation of Akums Drugs & Pharmaceuticals?

Ans. Akums Drugs & Pharmaceuticals has a market capitalisation of Rs 12,338.9 crore. That places the company well above the same-industry median market cap of Rs 729.99 crore in the supplied benchmark set.

What is the P/E ratio for Akums Drugs & Pharmaceuticals?

Ans. Akums Drugs & Pharmaceuticals has a P/E ratio of 44.31. In the same-industry benchmark, that is above the median of 32.39 and below the average of 49.54. The company trades at a P/E ratio of 44.31x.

What do ROE and ROCE show for Akums Drugs & Pharmaceuticals?

Ans. ROE is 8.06% and ROCE is 14.77%. ROE is below the industry median of 11.78%, while ROCE is above the median of 13.61% in the same benchmark set. ROE stands at 8.06%.

What are the EPS and book value for Akums Drugs & Pharmaceuticals?

Ans. EPS is Rs 18.53 and book value per share is Rs 216.98. EPS shows earnings attributable to each share, while book value reflects the accounting net worth behind each share.

How does Akums Drugs & Pharmaceuticals compare with peers?

Ans. Akums Drugs & Pharmaceuticals has a lower P/E than several peers such as Sudeep Pharma, CORONA Remedies, Sequent Scientific and Blue Jet Healthcare, but its ROE is below all five listed peers in the supplied peer set.

Where can I track Akums Drugs & Pharmaceuticals Share Price live?

Ans. You can track Akums Drugs & Pharmaceuticals Share Price on Univest for live price updates, 52-week levels, market capitalisation, fundamentals and shareholding context. Univest presents the stock in a structured, research-style format.